Daniele Rigamonti is a Neurosurgery provider in Baltimore, Maryland. Dr. Rigamonti is rated as a Distinguished provider by MediFind in the treatment of Glomus Jugulare Tumor. Her top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Pseudotumor Cerebri Syndrome, Increased Intracranial Pressure, and Stent Placement.

David Eisenman is an Otolaryngologist in Baltimore, Maryland. Dr. Eisenman is rated as a Distinguished provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Tinnitus, Acoustic Neuroma, Schwannoma, Hearing Loss, and Tissue Biopsy.

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is rated as an Advanced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Hepato-Pancreato-Biliary Surgery, and Gamma Knife Radiosurgery.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Advanced provider by MediFind in the treatment of Glomus Jugulare Tumor. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Kyle Hatten is an Otolaryngologist in Baltimore, Maryland. Dr. Hatten is rated as an Advanced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Laryngeal Cancer, Laryngectomy, and Gastrostomy. Dr. Hatten is currently accepting new patients.

David Smith is a Hematologist and an Oncologist in Easton, Maryland. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Adult Immune Thrombocytopenia, and Myelodysplastic Syndrome (MDS).

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Ganglioneuroblastoma.

Neurotologist John Carey specializes in the health and diseases of the inner ear that affect both balance and hearing mechanisms. He is a national expert in superior canal dehiscence syndrome, Menière’s disease, vestibular migraine, acoustic neuromas and other causes of vertigo, and serves as chief of the Division of Otology, Neurotology and Skull Base Surgery in the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Carey earned a medical degree from Washington University School of Medicine and completed two years of training in general surgery at Virginia Mason Medical Center. This was followed by residency training in otolaryngology–head and neck surgery at University of Washington Medical Center and fellowship training in neurotology at the Johns Hopkins University School of Medicine. His research interests include superior canal dehiscence syndrome, Menière’s disease, vestibular implants, and the mechanisms of vestibular migraine. He has a particular interest in superior canal dehiscence syndrome, and, with Lloyd Minor, department director from 2003 to 2009, he helped develop the operation used to repair the superior canal. Dr. Carey has been funded by the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health. He has authored or co-authored over 150 peer-reviewed publications, 10 book chapters, and 11 reviews. Dr. Carey is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Vertigo, Meniere Disease, Acoustic Neuroma, Mastoidectomy, and Endoscopy.

Young Kwok is a Radiation Oncologist in Columbia, Maryland. Dr. Kwok is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Brain Tumor, Small Cell Lung Cancer (SCLC), and Prostatectomy.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

Charles C. Della Santina specializes in surgery for treatment of hearing, balance and other ear disorders including otosclerosis, cholesteatoma, conductive and sensorineural hearing loss, acoustic neuroma/vestibular schwannoma, glomus and other tumors of the temporal bone, and other problems that cause hearing loss or abnormal vestibular (inner ear balance) sensation. He is the director of the Johns Hopkins Cochlear Implant Center. He performs acoustic neuroma surgery, cochlear implantation, stapes surgery, middle ear bone reconstruction, bone-conduction hearing device implantation, other middle ear and mastoid surgeries, removal of glomus and other temporal bone tumors, surgical treatment of temporal bone cerebrospinal fluid leaks and encephaloceles, and surgery for vestibular disorders including superior canal dehiscence syndrome, Meniere’s disease, bilateral loss of vestibular sensation, gentamicin ototoxicity and other disorders. Dr. Della Santina earned a medical degree from the University of California San Francisco School of Medicine and a doctorate in biomedical engineering from the University of California, Berkeley College of Engineering. He completed residency training in otolaryngology at the Johns Hopkins University School of Medicine in 2002, and has served on the Johns Hopkins faculty since then. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. His group’s world-leading research on vestibular implantation has been published in leading journals including the New England Journal of Medicine. Dr. Della Santina's more than 140 publications also include studies of inner ear physiology and anatomy, new clinical tests of vestibular function, and the effects of cochlear implantation, superior canal dehiscence syndrome and gentamicin on the inner ear. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. Dr. Della Santina's more than 110 publications also include studies of inner ear physiology and anatomy; new clinical tests of vestibular function; and the effects of cochlear implantation, superior canal dehiscence syndrome, and gentamicin on the inner ear. Dr. Santina is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Jones Syndrome, Infant Hearing Loss, DFNB1, and Vertigo.

Dr. Matthew Stewart specializes in surgery of the inner ear, skull-base tumors, sudden hearing loss, surgical restoration of hearing through cochlear implantation, stapes surgery for otosclerosis and Bone Anchored Hearing Aid (BAHA). His research focuses on auditory processing in BAHA and health care quality implementation in microsystems. Dr. Stewart is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Acoustic Neuroma, Schwannoma, Infant Hearing Loss, DFNB1, and Myringotomy.

Dr. Creighton is an ear and lateral skull base surgeon. Dr. Creighton graduated from the Georgia Institute of Technology with a Bachelor of Science in biomedical engineering and earned his M.D. from Emory University. He completed a general surgery internship at the Mass General Hospital and residency in otolaryngology-head and neck surgery at Harvard. Following this he completed a fellowship in neurotology and lateral skull base surgery at Johns Hopkins. His clinical practice specializes in surgical and medical management of middle ear, inner ear, skull base and facial nerve disorders. These include skull base tumors, vestibular schwannomas (acoustic neuromas), hearing loss, cholesteatoma, cochlear implantation, stapedectomy, CSF leaks and ear drum perforations. He is trained in minimally invasive and endoscopic approaches to the ear for cholesteatoma and ear drum perforations, which reduces the need for visible incisions, and performed the first in office tympanoplsty repairs at Johns Hopkins. Dr. Creighton is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Acoustic Neuroma, Schwannoma, Infant Hearing Loss, Mastoidectomy, and Septoplasty.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. Her top areas of expertise are Prostate Cancer, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Adenoidectomy.

Head and neck surgeon David Eisele specializes in surgery for malignant and benign tumors of the head and neck, with a focus on salivary gland neoplasms and disorders of the salivary glands that can be treated surgically. He is an expert in minimally invasive surgical approaches, including sialendoscopy. Salivary gland neoplasms and disorders are also the focus of Dr. Eisele’s research. He has published more than 300 research papers and edited multiple books related to head and neck surgery. Dr. Eisele earned a medical degree from Cornell University Medical College and completed residency training in general surgery and in otolaryngology–head and neck surgery at the University of Washington. From 2012 to 2025, he served as director of the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Eisele is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Salivary Duct Stones, Salivary Gland Tumors, Throat Cancer, Laryngectomy, and Gastrostomy.

Roberto Rey Dios is a Neurosurgery provider in Baltimore, Maryland. Dr. Rey Dios is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Pituitary Tumor, Subdural Hematoma, Primitive Neuroectodermal Tumor (PNET), Balloon Sinuplasty, and Awake Craniotomy.

Fraser Henderson is a Neurosurgery provider in Silver Spring, Maryland. Dr. Henderson is rated as an Experienced provider by MediFind in the treatment of Glomus Jugulare Tumor. His top areas of expertise are Glioma, Gliomatosis Cerebri, Meningioma, Vitrectomy, and Tissue Biopsy. Dr. Henderson is currently accepting new patients.